Skip to content
Just in Time GCP
  • Home
  • About
  • Services
    • All Services
    • In-Demand Services
    • Clinical Innovation
  • News
  • Careers
  • Contact
  • Home
  • About
  • Services
    • All Services
    • In-Demand Services
    • Clinical Innovation
  • News
  • Careers
  • Contact

Day: September 24, 2025

ICH E6(R3) Risk Management and Oversight

Posted on September 24, 2025 by Carol Wiley

ICH E6(R3) Risk Management and Oversight: A Priority Update for Sponsors ICH E6(R3) introduces new expectations for oversight, data integrity, and quality. Sponsors now face pressure to prioritize process updates so their teams don’t waste time or miss critical risks. At Beyond Clinical Compliance, on September 9th in Philadelphia, Donna Dorozinsky addressed this challenge in […]

Read more

Filed under: Uncategorized

Recent Posts

  • ICH E6(R3) Risk Management and Oversight
  • Redefining Risk in the R3 Era
  • AI in Site Personnel Oversight
  • GCP Directions – Simplifying Clinical Compliance
  • Learnings from the 2025 Veeva R&D Summit

Recent Comments

  • rutrum on 4 Reasons Why GCP Compliance Is Important
  • etiam on Insights from the 2024 Veeva R&D and Quality Summit
  • lyonnais on Welcome Aaron Grant as Head of Innovation
  • modishly on Employee Spotlight – Ralf Brooks
  • shiatzus on The Recent FDA Draft Guidance on Processes & Practices Applicable to a BIMO Inspection

Archives

  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024

Categories

  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • About
  • Services
  • Contact
  • Careers
  • Privacy Notice
  • About
  • Services
  • Contact
  • Careers
  • Privacy Notice
215-343-4484
info@justintimegcp.com
© 2025 Just In Time GCP - All Rights Reserved
Twitter Linkedin